Detection of a bowel cancer marker (CDH1) in wastewater may offer a new community-level early warning system for the disease, ...

Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in Nature ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

Wastewater-based epidemiology is feasible as a community-level and population-level surveillance tool for colorectal cancer (CRC), according to a study published online March 17 in the Journal of ...

Background Individual screening for colorectal cancer (CRC) is typically performed through either direct clinical examination ...

Someday soon, doctors who don’t run their patients’ records through an AI model will be considered negligent. At least, that’s what Steve Brown thinks. He’s the founder of CureWise, an app designed to ...

Building on her discovery of the GLP-1 signaling pathway's role in sarcoma biology, Erica Pimenta, MD, PhD, of the Dana-Farber Cancer Institute, is exploring the therapeutic poten ...

Nano-therapeutics represent a transformative advancement in precision cancer medicine, offering the promise of more effective and targeted treatment options. By harnessing the unique properties of ...

T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.

A collaborative research team has uncovered a previously unknown mechanism of action of yaku'amide B, a structurally complex peptidic natural product derived from deep-sea sponge found in the waters ...

Cancer is the second-leading cause of death in the United States, accounting for over 613,000 fatalities in 2023, per the Centers for Disease Control. But the field of cancer vaccines, which can be ...